Price Target $15 Bio Blast Pharma Ltd (NASDAQ:ORPN) had its "buy" rating reaffirmed by analysts at Roth Capital ( ). They now have a $15.00 price target on the stock, down previously from $23.00. 639.2% upside from the previous close of $2.03
Bargin buy forsure right now!
/cheers
GLTA DYODD